SAB Biotherapeutics SABS Revenue Breakdown

NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST
No revenue breakdown for SABS SAB Biotherapeutics does not report revenue split by segment, product or geography.